These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23337541)

  • 1. Impact of shock energy and ventricular rhythm on the success of first shock therapy: the ALTITUDE first shock study.
    Cha YM; Hayes DL; Asirvatham SJ; Powell BD; Cesario DA; Cao M; Gilliam FR; Jones PW; Jiang S; Saxon LA
    Heart Rhythm; 2013 May; 10(5):702-8. PubMed ID: 23337541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks.
    Strik M; Ramirez FD; Welte N; Bonnin T; Abu-Alrub S; Eschalier R; Haïssaguerre M; Ritter P; Ploux S; Bordachar P
    Heart Rhythm; 2020 Dec; 17(12):2072-2077. PubMed ID: 32739474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.
    Sullivan RM; Russo AM; Berg KC; Stolen KQ; Seth M; Perschbacher D; Day JD; Olshansky B
    Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
    Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
    Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
    Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ICD Therapies on Mortality in the OMNI Trial.
    Sun S; Johnson J; Degroot P; Brown ML; Obel O
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):192-9. PubMed ID: 26501695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology and Programming Effects on Shock Efficacy in ICD Recipients.
    Bertomeu-González V; Moreno-Arribas J; Castillo-Castillo J; Martínez-Ferrer J; Viñolas X; Rodríguez A; Díaz-Infante E; Fernández-Lozano I; Alzueta J; Fontenla A
    Pacing Clin Electrophysiol; 2016 Jan; 39(1):73-80. PubMed ID: 26450114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitachycardia pacing reduces appropriate and inappropriate shocks in children and congenital heart disease patients.
    Kalra Y; Radbill AE; Johns JA; Fish FA; Kannankeril PJ
    Heart Rhythm; 2012 Nov; 9(11):1829-34. PubMed ID: 22766560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Antitachycardia Pacing or Shocks With Survival in 69,000 Patients With an Implantable Defibrillator.
    Strickberger SA; Canby R; Cooper J; Coppess M; Doshi R; John R; Connolly AT; Roberts G; Karst E; Daoud EG
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):416-422. PubMed ID: 28128491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
    Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
    Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety margins: lessons from the Low Energy Endotak Trial (LEET).
    Neuzner J
    Am J Cardiol; 1996 Sep; 78(5A):26-32. PubMed ID: 8820833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefit of a second burst antitachycardia sequence for fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Anguera I; Dallaglio P; Sabaté X; Nuñez E; Gracida M; Di Marco A; Sugrañes G; Cequier A
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):486-94. PubMed ID: 24215374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmic episodes in patients implanted with a cardioverter-defibrillator - results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P).
    Regoli F; Graf D; Schaer B; Duru F; Ammann P; Stefano LMDS; Naegli B; Burri H; Zbinden R; Krasniqi N; Fromer M;
    BMC Cardiovasc Disord; 2019 Jun; 19(1):146. PubMed ID: 31208342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with the new cardioverter-defibrillator Ventak PRxII].
    Pfitzner P; Trappe HJ; Fieguth HG; Kielblock B
    Z Kardiol; 1995 Apr; 84(4):275-83. PubMed ID: 7785299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F
    Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
    Dallaglio PD; Anguera I; Martínez Ferrer JB; Pérez L; Viñolas X; Porres JM; Fontenla A; Alzueta J; Martínez JG; Rodríguez A; Basterra N; Sabaté X
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):709-717. PubMed ID: 29242102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Sivagangabalan G; Eshoo S; Eipper VE; Thiagalingam A; Kovoor P
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1095-9. PubMed ID: 18834458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.